Beta Finch - S&P 100 - EN

More earnings analysis: https://betafinch.com
Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take a dense earnings call and turn it into a conversation that actually makes sense. I'm Alex.

JORDAN: And I'm Jordan. Today we're digging into Illinois Tool Works — ITW — Q2 2026. And Alex, this was a genuinely strong print.

ALEX: Before we get into it — quick disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Okay, with that out of the way — Jordan, ITW basically had the best quarter in company history.

JORDAN: They did. Organic growth of 4.5%, operating margin at 26.7%, GAAP EPS up 10% to $2.84, and operating income hit $1.15 billion — a 7.4% jump. That's the most profitable quarter ITW has ever put up.

ALEX: And it wasn't one lucky segment carrying the load. Welding grew organically 14%, Test & Measurement and Electronics grew 10%, Polymers and Fluids grew 7%. These are the CapEx-heavy, cyclical parts of the business, and they just accelerated hard.

JORDAN: Right, and the sequential story is what really jumped out to me. Revenue grew 7% quarter-over-quarter versus a historical average of about 2%. That's not incremental improvement, that's a genuine inflection.

ALEX: So naturally, they raised guidance. Full-year organic growth guidance moved up a point and a half to a new midpoint of 3.5%. GAAP EPS guidance rose 15 cents to a midpoint of $11.45 — that's 9% year-over-year growth, and it's their second guidance raise this year.

JORDAN: What I want to flag for listeners is CBI — Customer-Back Innovation. This is ITW's structured innovation framework, and it contributed 3% to revenue growth in the first half, up from 2.4% for all of 2025. CEO Chris O'Herlihy compared building this discipline to how they rolled out their famous 80/20 operating model over a decade ago.

ALEX: And it's not just a talking point — it's tied to compensation now. Every division from the ground up is incentivized on it, and importantly it's measured as truly incremental revenue, net of cannibalization, over a rolling three-year window. So a new product's contribution eventually rolls off unless something new replaces it.

JORDAN: Which is a nice built-in forcing function to keep innovating rather than resting on one hit product.

ALEX: Let's talk about welding for a second, because a 14% organic growth number in an industrial business is huge. North America — about 85% of that segment — grew 19%, with strength across infrastructure, energy, aerospace, and defense.

JORDAN: And margins there stayed best-in-class at 32.4%, though a couple of analysts on the call pushed back asking if that's a ceiling. Management said no — the near-term drag is really just a price-cost timing lag from raw material inflation, not a structural limit. Once pricing catches up, they expect incrementals back to that 40%-plus range.

ALEX: Speaking of price-cost — that was probably the most repeated phrase on this call.

JORDAN: For sure. CFO Michael Larson said price increases more than offset higher raw material costs in dollar terms, but the timing lag diluted margins by about 40 basis points in Q2. Crude oil derivatives — resin, chemicals — were the main culprits, hitting specialty products and automotive the hardest.

ALEX: But he was pretty clear this is temporary and something they've navigated before, pointing to the first and second rounds of tariffs as precedent. They expect the drag to shrink to around 30 basis points in Q3 and 20 in Q4.

JORDAN: One worry I'd flag for listeners: there's also a real one-time event here — a storm damaged two welding facilities in Appleton, Wisconsin, right before the call. Everyone's safe, and management says no mater

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX**: Welcome back to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with Jordan to dive into Illinois Tool Works' latest earnings call. Jordan, ITW just delivered what looks like a solid finish to 2025 and some pretty optimistic guidance for 2026.

**JORDAN**: Absolutely, Alex. But before we get into the numbers, let me remind our listeners that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks for that important reminder. Now, let's talk ITW. The industrial conglomerate posted some impressive results - Q4 revenue growth of over 4%, with organic growth of 1.3%, and a 7% increase in GAAP EPS to $2.72. But what really caught my eye was their operating margin hitting record levels at 26.5%.

**JORDAN**: Those margins are eye-popping, Alex. What's driving that performance is their "enterprise initiatives" - basically their continuous improvement programs - which contributed 140 basis points to margins in Q4 alone. And here's the kicker: they're projecting another 100 basis points of margin improvement in 2026 from these same initiatives.

**ALEX**: That's massive. Let's talk about their guidance for 2026. They're projecting organic growth of 1% to 3%, total revenue growth of 2% to 4%, and EPS growth of 7% at the midpoint of $11.20. Jordan, what's your take on these numbers?

**JORDAN**: What strikes me is the quality of this guidance, Alex. CEO Chris O'Herlihy emphasized that their incremental margins are running in the "mid to high forties" - that's well above their historical 35-40% range. CFO Michael Larsen explained this isn't just about getting lucky with market conditions. They've fundamentally improved their portfolio quality through years of what they call "PLS" - product line simplification - essentially pruning weaker products and focusing on their best performers.

**ALEX**: Speaking of focus, let's dive into their Customer-Backed Innovation, or CBI initiative. This seems to be a real growth driver for them.

**JORDAN**: CBI is fascinating, Alex. They achieved 2.4% revenue growth from customer-backed innovation in 2025 - that's a 40 basis point improvement year-over-year. But here's what's really interesting: their patent filings increased 18% in 2024 and another 9% in 2025. O'Herlihy called this a "leading indicator" because their patents typically protect customer solutions, suggesting future revenue growth is in the pipeline.

**ALEX**: And they're targeting 3% plus CBI contribution by 2030. That's become so important to their strategy that they've actually added it to their executive compensation plans. Now, during the Q&A, there were some interesting questions about specific segments. What stood out to you?

**JORDAN**: The semiconductor discussion was compelling. Their test and measurement segment saw semis up mid-single digits in Q4 after what had been a challenging year. Andy Kaplowitz from Citi asked about whether this was sustainable, given they'd seen "head fakes" before. O'Herlihy was cautiously optimistic - semis represent about 15% of their test and measurement business, or roughly 3% of total ITW. He emphasized they're well-positioned to take market share as that sector recovers.

**ALEX**: The China story is also worth highlighting. They grew 9% there for the full year, with automotive OEM up 12%. That's largely driven by their success in the EV market, where they've made significant investments over recent years.

**JORDAN**: Exactly. China represents about 65% of worldwide EV builds, and ITW has positioned themselves well with Chinese OEMs, who now represent 70% of that market. They're expecting mid to

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're diving into Intuitive Surgical's second quarter 2026 results. Before we get going, I do need to say — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: And with that out of the way, Alex, this was actually a pretty strong quarter for Intuitive on paper.

ALEX: It was. Revenue up 19% to $2.89 billion, non-GAAP EPS up 28% to $2.80 a share, operating margin at 42%. Total procedures grew 16%, with da Vinci procedures up 15% and Ion — their lung biopsy platform — up a huge 36%.

JORDAN: There's a wrinkle in that gross margin number though. It came in at 70%, but $36 million of that was a one-time tariff refund benefit. Strip that out and you're looking at 68.7%, which is still solid, but worth noting when you're comparing quarters.

ALEX: Right, and they actually raised full-year gross margin guidance because of that — now 68% to 69%, up from 67.5% to 68.5%. But here's the part that got analysts' attention: U.S. da Vinci procedure growth moderated to 12%, down from 14% in Q1.

JORDAN: Yeah, and CFO Jamie Samath was pretty direct about why. They're seeing signs that patients are deferring elective procedures, and they specifically flagged the expiration of ACA enhanced premium subsidies as a factor. Basically, when people's insurance costs go up or coverage gets murkier, they push off surgeries that can wait.

ALEX: The CEO, Dave Rosa, made a point of saying the underlying disease burden hasn't changed — people aren't getting healthier, they're just delaying care. Which, if you're an investor, is either reassuring or a "wait and see," depending on how you read it.

JORDAN: There's also the GLP-1 story continuing to play out — bariatric procedures in the U.S. declined high-single-digits this quarter as more patients manage weight through drugs like Ozempic instead of surgery.

ALEX: Let's talk strategy, because there was a lot packed into this call. The big one: the Extended Use Program. Starting in early 2027, Intuitive plans to increase the number of uses allowed on a subset of their EndoWrist instruments, specifically targeting lower-cost, high-volume benign procedures.

JORDAN: This is a classic Intuitive move — they did something similar back in 2020. The idea is: lower the cost per procedure for hospitals, which drives more adoption, which drives more scale. An analyst on the call, Travis Steed, tried to get them to size the financial impact — he was fishing for whether this repeats the roughly 7-point hit to instrument revenue per procedure they saw last time.

ALEX: And management wouldn't bite. Jamie Samath said flat out they're not ready to quantify it and will give more detail next quarter. So that's a real overhang to watch heading into 2027 guidance.

JORDAN: The other big theme was geographic. China remains genuinely tough — increased domestic robotic competition, pricing pressure, and a new centralized tender process the government is rolling out. Dave Rosa was careful to say it's not quite the same as the volume-based pricing programs we've seen hit other device makers, but it's clearly something to watch.

ALEX: Japan, on the other hand, looked more encouraging. New reimbursement policies kicked in June 1st, and they already saw system placements jump — 25 systems in Japan this quarter versus 15 a year ago.

JORDAN: And then there's da Vinci 5, which is really the growth engine right now. They placed 468 total da Vinci systems, 246 of those were da Vinci 5, including 114 dual-console setups. The installed base is over 1,700 systems and 15,000 surgeons trained on it already.

ALEX: One thing that stood out to me in t

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
# Beta Finch Podcast Script: Intuitive Surgical Q4 2025 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're unpacking Intuitive Surgical's Q4 2025 results - and folks, this robotics giant just delivered some seriously impressive numbers.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, where do we even start with these results? Intuitive absolutely crushed it this quarter. We're talking about a company that just crossed the 20 million patient milestone since 1997 and shows no signs of slowing down.

**ALEX:** Let's hit the headline numbers first. Revenue grew 21% to hit $10.1 billion for the full year - that's massive growth for a company this size. And quarterly revenue was up 19% to $2.87 billion. But Jordan, what really caught my eye was the procedure growth.

**JORDAN:** Absolutely. Total procedures grew 19% for the year to over 3.1 million. That's not just impressive - it's accelerating adoption of robotic surgery worldwide. Da Vinci procedures specifically were up 18%, with their single-port procedures exploding 87% year-over-year. That tells me surgeons are really embracing these newer technologies.

**ALEX:** And geographically, the story gets even better. US procedures grew 15%, but international was the real star - up 23% with particularly strong performance in Europe at 21%, Asia at 24%, and rest of world markets at 27%. It's becoming a truly global story.

**JORDAN:** What I found fascinating was the capital equipment side. They placed 1,721 da Vinci systems in 2025, including 870 of their newest da Vinci 5 systems. The demand for upgrades is clearly there, especially with the dual console systems for training and mentoring. That speaks to hospitals really investing in their robotic surgery capabilities long-term.

**ALEX:** Let's talk margins for a second. Operating margins came in at 37%, which is solid, though they're dealing with some headwinds. CEO David Rosa mentioned tariffs are hitting them for about 95 basis points, plus they're investing heavily in R&D and scaling manufacturing. But they're managing it well with cost efficiency initiatives.

**JORDAN:** The tariff impact is significant - they're forecasting 120 basis points of impact in 2026, up from about 65 basis points in 2025. That's a real cost pressure they're navigating. But here's what's interesting - they're still guiding for gross margins of 67-68% in 2026, essentially flat despite these headwinds.

**ALEX:** Now, one of the most exciting developments from this call was the FDA clearance for cardiac procedures on the da Vinci 5. Jordan, this could be huge, right?

**JORDAN:** Potentially massive, Alex. They performed about 17,000 cardiac procedures globally in 2025, which sounds small, but Rosa mentioned the addressable market for da Vinci 5 in just the US and Korea is around 160,000 procedures annually. Cardiac surgery is complex, high-value work, so even modest penetration could move the needle significantly.

**ALEX:** The Q&A session revealed some really interesting strategic directions. They're making a big push into ambulatory surgery centers - ASCs. Rosa explained they're targeting higher-volume ASCs, particularly those affiliated with existing hospital customers where surgeons are already da Vinci trained.

**JORDAN:** That ASC strategy is smart. About 70% of the ASC opportunity is with their existing IDN customers, so they have built-in relationships and trained surgeons. They're using their refurbished XI

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're diving into Intel's Q2 2026 numbers, and there's a lot to unpack here. But before we get into it — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: And Alex, this was not a quiet quarter from Intel. Seventh straight quarter of beating guidance, and CEO Lip-Bu Tan called it the strongest revenue growth in over 15 years.

ALEX: Let's start with the headline numbers. Q2 revenue came in at $16.1 billion, that's $1.8 billion above the midpoint of guidance. Non-GAAP gross margin was 41.8%, about 280 basis points better than expected. And EPS was $0.42 versus guidance of just $0.20.

JORDAN: That EPS beat is huge — more than double the guide. And it wasn't just financial engineering. CFO Dave Zinsner said it was driven by higher revenue, better yields, and higher ASPs from mix and pricing. Operating cash flow was $7 billion, and they're sitting on about $30 billion in cash and short-term investments.

ALEX: The big theme of this call, though, is supply versus demand. Intel says demand is outpacing supply across basically everything — leading-edge logic, wafers, memory, substrates. Zinsner put a number on it too, noting they were undershipping demand by more than a billion dollars last quarter.

JORDAN: Which is a good problem to have, but it does mean they're leaving revenue on the table. That's part of why CapEx is jumping — they're now guiding to more than $20 billion for 2026, up significantly from where they started the year, and 2027 CapEx is expected to be significantly higher still.

ALEX: Let's talk segments, because there's a real divergence here. Data Center and AI, DCAI, was the star — $6.3 billion in revenue, up 24% sequentially and 59% year-over-year. Operating profit there was $2.5 billion, 40% margin, up about a billion dollars quarter-over-quarter.

JORDAN: Server CPU growth was described as the strongest on record. Xeon 6 is one of the fastest-ramping products in company history. And they launched Xeon 6+, codenamed Clearwater Forest — that's their first server chip built on the 18A process.

ALEX: On the client side — CCPG, which used to just be the PC business, now rebranded to include physical AI — revenue was $8.9 billion, up 15% sequentially. But Zinsner was pretty candid that the strength was mostly ASP-driven, some mix, some price increases to offset rising costs, rather than unit growth.

JORDAN: And that's an important nuance for listeners. The underlying PC market is actually expected to be sub-seasonal in the second half, down low double digits for all of 2026, largely because of rising memory prices and constraints. So client revenue holding up is really about pricing power and product mix skewing toward higher-end chips, not a booming PC market.

ALEX: There was also a notable inventory charge in client — about $173 million hit to operating profit — tied to products that weren't fully completed due to chipset shortages. Intel decided it made more sense to redirect that capacity elsewhere.

JORDAN: Now, Intel Foundry — this is the piece everyone watches closest given the turnaround story. Foundry revenue was $5.8 billion, up 6% sequentially, with 18A output up more than 50% quarter-over-quarter and running about 25% above internal targets. External foundry revenue specifically was $293 million — still small, but the operating loss narrowed to $2.1 billion, improving $348 million from last quarter.

ALEX: And they gave a real cost data point — Panther Lake's primary SKU cost is down roughly 50% year-to-date, with another 20% reduction targeted by year-end.

JORDAN: The forward-looking piece that stood out to me wa

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS)
──────────
# Beta Finch Podcast Script - Intel Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're unpacking Intel's first quarter 2026 results, and wow - what a turnaround story this is becoming.

**ALEX:** Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about Intel because this earnings call felt like listening to a completely different company than we were hearing from just a year ago.

**ALEX:** You're not wrong, Jordan. CEO Lip Bu Tan literally said "A year ago, the conversation about Intel Corporation was about whether we could survive. Today, it's about how quickly we can add manufacturing capacity." That's quite the transformation narrative.

**JORDAN:** The numbers certainly back that up. Intel delivered $13.6 billion in revenue for Q1, which was $1.4 billion above the midpoint of their guidance. That's their sixth consecutive quarter of beating expectations. EPS came in at 29 cents versus guidance of breakeven.

**ALEX:** And here's what really caught my attention - they're saying demand is outpacing supply across all their businesses, especially in server CPUs. CFO Dave Zinsner said they're missing out on revenue that "starts with a 'b'" - meaning billions in unmet demand.

**JORDAN:** That supply constraint story is fascinating because it's driven by what they're calling the AI infrastructure buildout. Let's break down their segments. Data Center and AI revenue hit $5.1 billion, up 22% year-over-year, with ASIC revenue doubling. Meanwhile, Client Computing was $7.7 billion.

**ALEX:** The AI story Intel is telling is particularly interesting. They're positioning CPUs as becoming more critical as AI moves from training to inference and into what they call "agentic" applications. Lip Bu mentioned that the ratio of CPUs to GPUs used to be 1-to-8, but it's moving toward 1-to-4 and could reach parity.

**JORDAN:** That's a massive shift if it plays out. And they're backing it up with some big partnerships. They announced a multiyear deal with Google and this intriguing collaboration with Elon Musk's companies - SpaceX, xAI, and Tesla - for something called "TeraFab."

**ALEX:** The Elon partnership is pretty wild. Lip Bu said they both believe global semiconductor supply isn't keeping pace with demand, and they want to "explore innovative ways to refactor silicon process technology." Very typical Elon - thinking outside the box on manufacturing efficiency.

**JORDAN:** Let's talk about their foundry business because that's been the big question mark. Intel Foundry revenue was $5.4 billion, up 20% sequentially, though they're still losing $2.4 billion operationally. But here's the key - their 18A process node is running ahead of internal projections.

**ALEX:** Right, and they're getting more confident about external foundry customers. Dave Zinsner said their advanced packaging backlog is now in the "billions of dollars" range, not the hundreds of millions they initially expected. That's a significant scale-up.

**JORDAN:** The guidance for Q2 is solid too - $13.8 to $14.8 billion revenue, with both client and data center segments expected to grow sequentially. Though they are warning about PC market weakness in the second half and some margin pressure from ramping 18A production.

**ALEX:** Speaking of margins, gross margin came in at 41% for Q1, way ahead of guidance, though they're guiding 39% for Q2. The 18A ramp is creating some near-term headwinds, but the volume growth and yield i

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS)
──────────
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're unpacking Intel's Q4 2025 earnings call, and wow - there's a lot to discuss here.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, Intel's been on quite a journey lately, especially with new CEO Lip-Bu Tan at the helm. What were the headline numbers?

**ALEX**: The numbers actually look pretty solid on the surface. Q4 revenue came in at $13.7 billion - that's at the high end of their guidance range. They delivered non-GAAP earnings per share of 15 cents versus guidance of just 8 cents. And here's something interesting - this marks their fifth consecutive quarter of beating guidance.

**JORDAN**: That's a nice streak, but I'm sensing there's a "but" coming here, right?

**ALEX**: You know me too well, Jordan. The big story here isn't what they delivered - it's what they couldn't deliver due to supply constraints. CEO Lip-Bu Tan was pretty candid about this. He said they're "disappointed that we are not able to fully meet the demand in our markets."

**JORDAN**: Supply constraints in a chip shortage - where have we heard that before? But what's driving the demand they can't meet?

**ALEX**: It's all about AI infrastructure build-out. Their traditional server business saw 15% sequential growth - the fastest this decade, according to CFO Dave Zinsner. AI PCs were up 16% in units. But here's the kicker - Zinsner said revenue "would have been meaningfully higher if we had more supply."

**JORDAN**: So they're essentially leaving money on the table. What about their guidance for Q1 2026?

**ALEX**: This is where it gets interesting. They're guiding to $11.7 to $12.7 billion for Q1, with a midpoint of $12.2 billion. That's actually below typical seasonality. Zinsner said they'd be "well above seasonal if we had all the supply."

**JORDAN**: That's a pretty significant admission. But I noticed something in the transcript - they're prioritizing server shipments over client. Can you explain that strategy?

**ALEX**: Exactly right. They're deliberately shifting their constrained wafer supply toward higher-margin data center customers and away from PC clients. It's a smart move financially, but it shows just how tight their supply situation really is. They've basically depleted their inventory buffers and are operating hand-to-mouth.

**JORDAN**: Let's talk about their foundry ambitions. Lip-Bu has been making a lot of noise about building a world-class foundry business. What's the latest there?

**ALEX**: This is probably the most forward-looking part of the call. They're shipping products on Intel 18A - which they claim is the most advanced process manufactured on U.S. soil. But the real excitement is around Intel 14A. They expect customers to start making firm supplier decisions in the second half of 2026, with volume production targeted for 2028.

**JORDAN**: That timeline puts them roughly in line with TSMC's advanced nodes. But there was some interesting commentary about advanced packaging too, wasn't there?

**ALEX**: Yes! Zinsner said their advanced packaging opportunities - particularly something called EMIB-T - could be "well north of $1 billion" per customer engagement. He initially thought these would be "hundreds of millions" but customer interest is way stronger than expected. Some customers are even making prepayments to secure capacity.

**JORDAN**: That's a strong vote of confidence. Now, one thing that caught my attention was their ASIC business hitting a $1 bil

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, bringing you straight talk on the numbers that move markets. I'm Alex.

JORDAN: And I'm Jordan. Today we're digging into Intercontinental Exchange — ticker ICE — and their Q2 2026 results, reported Thursday, July 30th. And Alex, there's a lot here, including a headline-grabbing acquisition.

ALEX: There really is. But first, the standard note — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, let's get into it. So ICE posted its best second quarter in company history. Adjusted EPS came in at $1.90 — a Q2 record. Net revenues hit $2.7 billion, up 5%, and recurring revenue was a record $1.4 billion, up 8%.

ALEX: And what's notable is this is compounding on top of already-record growth in Q2 2025. CFO Warren Gardiner made a point of saying this quarter's story wasn't a volatility spike like Q1 — it was durability. Recurring, sticky revenue holding up even as episodic trading activity cooled off a bit.

JORDAN: Right, and capital returns were strong too — $945 million back to shareholders this quarter, $1.8 billion in the first half, both records. Leverage sits at 2.8x, right in their target range.

ALEX: But Jordan, let's talk about the big news — the $5.7 billion acquisition of MarketAxess.

JORDAN: Yeah, this is the headline. ICE is paying $167 per share — a 33% premium — to buy MarketAxess, one of the leading electronic trading platforms for institutional bond markets. The strategic logic here is pretty elegant: ICE already dominates the retail and wealth side of fixed income trading through ICE Bonds. MarketAxess brings over 2,100 institutional clients — asset managers, pension funds, insurers.

ALEX: So you're connecting two liquidity pools that historically never talked to each other.

JORDAN: Exactly, and CEO Jeff Sprecher framed it as building "a global fixed income network" — retail flow meets institutional flow, all on common rails, layered with ICE's pricing and data. They're expecting about $100 million in annual expense synergies by year three, and management says it'll be accretive to earnings in year one.

ALEX: Though a couple analysts pushed back a bit in the Q&A — MarketAxess has had some market share erosion and pricing pressure. Sprecher's answer was basically: we've been circling this space for a decade, and now the pieces — the data business, the treasury clearinghouse, the wealth channel — are finally in place to make the combination work.

JORDAN: It's a cash deal, funded through bonds, a term loan, and commercial paper. Leverage will temporarily peak around 3.4x, but they're targeting back to 3x within 18 to 24 months. And despite taking on this debt, they're actually increasing quarterly buybacks from $350 million to $400 million.

ALEX: Confidence signal there. Let's talk segments, because the underlying business had a strong quarter on its own, deal aside. Exchanges segment — $1.5 billion net revenue, and the rates business grew 24% year-over-year.

JORDAN: That one's a great story. The ECB raised rates in June for the first time since 2023, and when central banks start moving — and moving in different directions from each other — that's exactly when ICE's European rate contracts get used. Open interest in their rates franchise hit a record 53 million contracts, up over 50% year-over-year.

ALEX: And here's a stat that stuck with me — the total value of positions across their Euribor, SONIA, and ESTR contracts hit $62.3 trillion in mid-June. That's triple where it was three years ago, and it now exceeds the comparable U.S. dollar rates market.

JORDAN: That's wild. Meanwhile, Fixed Income and Data Services net revenue was $645 million, up 8%, with their CDS clearin

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
**Beta Finch Podcast Script: IBM Q2 2026 Earnings**

---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into IBM's second quarter 2026 results.

JORDAN: And Alex, this is a juicy one — there was already a pre-announcement before the official call, so expectations were... managed, let's say.

ALEX: Before we get into it, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Solid. Okay, let's talk numbers. Revenue growth of just 1% for the quarter — that's a real miss for IBM, which has been on a growth acceleration story for a while now.

ALEX: Right, and CEO Arvind Krishna didn't sugarcoat it — he said flat out the quarter "fell short of expectations." But here's the twist: it wasn't a demand problem across the board, it was concentrated.

JORDAN: Exactly. CFO Jim Kavanaugh explained that in the final weeks of June, clients suddenly redirected spending toward servers, storage, and memory — basically rushing to lock in infrastructure ahead of expected price increases. That caused tens of large enterprise license deals to slip.

ALEX: And when those deals slip, it hits IBM's mainframe-and-software bundle hard. Transaction processing software revenue was down 9% for the quarter, and if you isolate the mainframe hardware itself, it was down 42% year over year.

JORDAN: Which sounds alarming, but context matters — that's coming off 70% growth in the same quarter last year during the z17 launch. And even with the dip, the z17 cycle is still running at nearly 130% program-to-program versus the z16 cycle, which was IBM's best ever.

ALEX: So it's more "lumpy" than "broken."

JORDAN: That's the bet management is making. And here's a number I liked — about 80% of IBM's software revenue is recurring, subscription or consumption-based, and that grew nicely, accelerating from 7% to 8% year over year. The real damage was isolated to that other 20%, the transactional, CapEx-sensitive chunk.

ALEX: Free cash flow was a bright spot too — $4.8 billion through the first half, flat year-over-year, and management reaffirmed guidance to grow full-year free cash flow by about $1 billion.

JORDAN: Which is honestly the more impressive headline given the revenue miss. Kavanaugh pointed to strong underlying EBITDA growth, plus they front-loaded a lot of the cash tax and CapEx headwinds earlier in the year, so those pressures ease up in the second half.

ALEX: Let's talk guidance — full-year revenue growth is now expected at 4% to 5%, down from the prior 5%-plus target. Software guidance moved to 6% to 8% for the year.

JORDAN: And this is the part analysts kept pushing on during Q&A — is this demand deferred, or demand destroyed? Arvind's answer was pretty specific: of the roughly ten large deals that slipped, about a third had already closed in just the first three weeks of the new quarter. He called that "a good indication, not yet full evidence" that clients are delaying, not canceling.

ALEX: He also had a great explanation for why it happened — clients apparently didn't realize alternate infrastructure purchases were jumping 30% in price quarter to quarter until crunch time, so they diverted budget there and pushed off other spending, including IBM software bundled with hardware purchases.

JORDAN: On the strategic side, there's a lot going on beyond the mainframe story. Distributed infrastructure — think Power and storage — had its best quarter of revenue growth on record, up 37%, with $500 million in backlog, the highest ever.

ALEX: And IBM's leaning hard into AI positioning — watsonx Orchestrate, Red Hat, the Confluent and HashiCorp acquisitions, all framed around this idea of being

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into IBM's Q1 2026 earnings - and wow, what a quarter this was for Big Blue.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, IBM just posted some pretty impressive numbers. Walk us through the highlights.

**ALEX:** The numbers really tell a story of transformation, Jordan. Revenue grew 6% to kick off 2026, but here's what caught my eye - free cash flow jumped 13% to $2.2 billion. That's their highest first quarter free cash flow in a decade.

**JORDAN:** And when you dig into the segments, you see why CEO Arvind Krishna was so confident on this call. Software revenue grew 8%, with their data business absolutely crushing it at 16% growth. Infrastructure was up 12%, and get this - their mainframe business grew 48%.

**ALEX:** That mainframe number is wild. And here's something fascinating from Krishna's commentary - he talked about how AI is creating entirely new use cases for mainframes. Instead of sampling just 10% of transactions for fraud detection, banks can now run AI inference on every single transaction directly on the platform.

**JORDAN:** That's a perfect example of how IBM is positioning itself in the AI revolution. They're not trying to build the next ChatGPT - they're building the infrastructure that lets enterprises actually use AI securely with their own data. Krishna made this point beautifully when he said they're helping clients "put AI to work on their terms."

**ALEX:** Speaking of AI positioning, one of the most interesting Q&A moments came when an analyst asked about IBM's software mix between infrastructure and applications. Krishna basically said only about 4% of their portfolio could be called applications - everything else is what he called "enabling software."

**JORDAN:** Which is brilliant positioning for the AI era, right? As agents start replacing some human interactions, the value isn't going to be in that interaction layer - it's going to be in the underlying data and business logic. IBM saw this coming and positioned their portfolio accordingly.

**ALEX:** Exactly. And the Confluent acquisition they closed early is a perfect example. This company streams live, governed data to AI models across hybrid environments. CFO Jim Kavanaugh said it should boost their data revenue by more than 15 percentage points.

**JORDAN:** The guidance update was interesting too. They're now projecting software growth of 10-plus percent for the year, up from their previous 10% target. But they kept their overall revenue guidance at 5-plus percent growth and free cash flow growth of about $1 billion.

**ALEX:** When analysts pressed them on why they didn't raise guidance after such a strong quarter, Kavanaugh had a great response. He said they've never raised guidance in the first quarter in his nine years as CFO, and they want to maintain their "beat mentality."

**JORDAN:** That discipline is probably why the stock has performed so well. But there were some concerns raised. One analyst noted that Red Hat's RHEL business decelerated, which Kavanaugh attributed to federal government budget closures and supply chain disruptions in the hardware market.

**ALEX:** The macro environment discussion was revealing too. Krishna said the Middle East actually had their strongest growth in decades - not years, decades. Europe was also strong. The only potential concern he flagged was if Middle East shipping routes stay disrupted for weeks, it could impact European

This episode includes AI-generated content.